Company Profile

Angstrom Pharmaceuticals Inc is a pharmaceutical firm focused to discovery of drugs that block the docking of an extracellular regulatory protein (ligand) to its receptor found on the outside of a cell - when this event is responsible for initiating a disease state. This is a new class of proprietary drugs that treat diseases involving cell migration, invasion, and metastasis. Ångstrom’s lead product, Å6 peptide, is a First-in-Class “Oncoparalytic”, stopping tumors from metastasizing by paralyzing cancer cells.Angstrom is developing new compounds for the treatment of diseases that are mediated through cell migration, invasion, angiogenesis and neovascularization. This includes cancer and wet age-related macular degener